Since the above publication, the authors have noticed that there are some errors in the western blots of Figures 1,4,6 and 7, which were unfortunately introduced when assembling the figures. The revised figures with the correct blots circled are shown below. The authors apologize for these errors, which did not affect the scientific content of the article. Figure 4 Caspase processing during Ad-XIAP-as-induced apoptosis. (a) LNT-229 cells were infected with 100 MOI Ad-EGFP or Ad-XIAP-as in the absence or presence of zVAD-fmk (100 mM) for different time periods. As a control for caspase cleavage, the cells were treated with 100 U/ml CD95L+10 mg/ml CHX for 4 h. Caspase processing and activation were visualized by the detection of p37 and p35/caspase-9, p12/ caspase-3, p20/caspase-7 (*) and p85/PARP; #: procaspase. Mitochondrial Cyt c release into the cytoplasm was assessed in parallel. b-Actin served as a reference. (b) The cells were infected with 100 MOI Ad-EGFP or Ad-XIAP-as for 16 h and assessed for the levels of cIAP1, cIAP2 or b-actin. (c) The cells were infected with 100 MOI Ad-XIAP-as in the absence or presence of zVAD-fmk (100 mM). cIAP-1, cIAP-2 and b-actin levels were assessed by immunoblot. 
